At Peptomyc we believe in forging strategic partnerships that will ultimately enable us to drive Myc inhibition into the clinic as an effective anti-cancer therapy across multiple tumor types. We therefore welcome your interest, questions or any queries you may have surrounding Peptomyc. Please do contact us directly:

 


Chief-Executive-Officer: Laura Soucek
Email: lsoucek@peptomyc.com


Chief-Scientific-Officer: Marie-Eve Beaulieu
Email: mbeaulieu@peptomyc.com


Strategic Consultant (Antares Consulting): Josep Lluís Falcó
Email: jfalco@peptomyc.com


Chief Financial Officer (Vantum Corporate): Jordi Petit Salamó
Email: jpetit@vantum-corporate.com